Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
- PMID: 16055622
- PMCID: PMC1747235
- DOI: 10.1136/thx.2005.040527
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
Abstract
Background: Patients with chronic obstructive pulmonary disease (COPD) often present with severe acute exacerbations requiring hospital treatment. However, little is known about the prognostic consequences of these exacerbations. A study was undertaken to investigate whether severe acute exacerbations of COPD exert a direct effect on mortality.
Methods: Multivariate techniques were used to analyse the prognostic influence of acute exacerbations of COPD treated in hospital (visits to the emergency service and admissions), patient age, smoking, body mass index, co-morbidity, long term oxygen therapy, forced spirometric parameters, and arterial blood gas tensions in a prospective cohort of 304 men with COPD followed up for 5 years. The mean (SD) age of the patients was 71 (9) years and forced expiratory volume in 1 second was 46 (17)%.
Results: Only older age (hazard ratio (HR) 5.28, 95% CI 1.75 to 15.93), arterial carbon dioxide tension (HR 1.07, 95% CI 1.02 to 1.12), and acute exacerbations of COPD were found to be independent indicators of a poor prognosis. The patients with the greatest mortality risk were those with three or more acute COPD exacerbations (HR 4.13, 95% CI 1.80 to 9.41).
Conclusions: This study shows for the first time that severe acute exacerbations of COPD have an independent negative impact on patient prognosis. Mortality increases with the frequency of severe exacerbations, particularly if these require admission to hospital.
Comment in
-
Effect of dichotomising age in multivariate model analysis.Thorax. 2006 Jun;61(6):548; author reply 548-9. Thorax. 2006. PMID: 16738050 Free PMC article. No abstract available.
Similar articles
-
Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.Respir Med. 2009 May;103(5):692-9. doi: 10.1016/j.rmed.2008.12.005. Epub 2009 Jan 7. Respir Med. 2009. PMID: 19131231
-
Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease.Respir Med. 2008 Apr;102(4):613-9. doi: 10.1016/j.rmed.2007.11.004. Epub 2007 Dec 20. Respir Med. 2008. PMID: 18083020
-
Recent improvement in long-term survival after a COPD hospitalisation.Thorax. 2010 Apr;65(4):298-302. doi: 10.1136/thx.2009.124818. Thorax. 2010. PMID: 20388752
-
The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.Am J Med. 2006 Oct;119(10 Suppl 1):63-72. doi: 10.1016/j.amjmed.2006.08.009. Am J Med. 2006. PMID: 16996901 Review.
-
Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?COPD. 2010 Aug;7(4):276-84. doi: 10.3109/15412555.2010.496817. COPD. 2010. PMID: 20673037 Review.
Cited by
-
Day-to-Day Variability of Parameters Recorded by Home Noninvasive Positive Pressure Ventilation for Detection of Severe Acute Exacerbations in COPD.Int J Chron Obstruct Pulmon Dis. 2021 Mar 22;16:727-737. doi: 10.2147/COPD.S299819. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33790549 Free PMC article.
-
Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.Int J Chron Obstruct Pulmon Dis. 2016 Aug 4;11:1857-65. doi: 10.2147/COPD.S103063. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27536097 Free PMC article.
-
Plasma Extracellular Vesicle miRNA Profiles Distinguish Chronic Obstructive Pulmonary Disease Exacerbations and Disease Severity.Int J Chron Obstruct Pulmon Dis. 2022 Nov 4;17:2821-2833. doi: 10.2147/COPD.S379774. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36381992 Free PMC article.
-
Six-Minute Walking Test and 30 Seconds Chair-Stand-Test as Predictors of Mortality in COPD - A Cohort Study.Int J Chron Obstruct Pulmon Dis. 2022 Oct 4;17:2461-2469. doi: 10.2147/COPD.S373272. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36217331 Free PMC article.
-
Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients.Sci Rep. 2016 Jun 28;6:28698. doi: 10.1038/srep28698. Sci Rep. 2016. PMID: 27350308 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical